Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type

NCT03714958 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Advanced Cancer
Metastatic Cancer

Interventions

DRUG: HDM201
DRUG: Trametinib

Sponsor

Centre Leon Berard

Collaborators

[object Object]